NIRUPAMA NATARAJAN: Open Payments
NPI 1942411251 · MILTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 26 payments from 7 companies in 2025. Trend: 2023 $1,814 · 2024 $2,307 · 2025 $1,574
Food & beverage: $1,574
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $432 |
| ABBVIE INC. | 8 | $270 |
| Tris Pharma Inc | 2 | $236 |
| E.R. Squibb & Sons, L.L.C. | 2 | $230 |
| Teva Pharmaceuticals USA, Inc. | 2 | $186 |
| Supernus Pharmaceuticals, Inc. | 2 | $137 |
| Otsuka America Pharmaceutical, Inc. | 1 | $83 |
Products named: Auvelity, VRAYLAR, Dyanavel XR, COBENFY, Qelbree, AUSTEDO XR, REXULTI, UZEDY.
Industry payments across GA — which companies pay providers there.
